Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline

Executive Summary

Price transparency reports from the big pharmas also show continued increases in price concessions in 2017, but a slow-down in list price increases.

You may also be interested in...



Big Brand Price Reductions Would Be Needed Without Rebates In Part D, Humana Warns

Insurer suggests manufacturers may not be willing to lower list prices enough to make up financial shortfalls in Medicare Part D that would be caused by restrictions on rebates.

Which Pharma Firm Increases US Prices The Most?

Transparency reports from companies aim to change conversation from prices to discounts, but also invite comparisons. Lilly, for example, saw a higher average list price increase in 2016 than Merck and Janssen, but its net prices grew by less than the others.

Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016

Eli Lilly recorded $7.69bn in rebates and discounts in the US in 2016 as pharmacy benefit managers demanded greater price concessions in crowded categories like diabetes.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS122843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel